DalsnaFinance Account

Chemours $CC

Materials

Russell 2000 Delaware

Create a scorecard

$12.98

+0.35 (+2.81%)

As of Oct 20, 2026, 3:50 PM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 13, 2026, the first target we tracked for CC.

Chemours (CC) is trading up at $12.98 (+2.81%), as of the latest quote. It is a Russell 2000 constituent in the Materials sector.

Analyst price targets on CC

One firm's current price target on Chemours: $14 — 8% above the current $13. Each is tracked to its date and scored the same way a member's call is.

RBC Capital Markets $13.4 → $14 by Oct 2027 Sector Perform Oct 13, 2026 via Investing.com · RBC Capital Markets's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Chemours revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

Chemours annual financial statements
	FY2016Dec 2016	FY2017Dec 2017	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$5.40B	$6.18B	$6.64B	$5.53B	$4.97B	$6.34B	$6.83B	$6.08B	$5.78B	$5.81B
Growth (year over year)	−5.5%	+14.5%	+7.4%	−16.8%	−10.1%	+27.7%	+7.7%	−11.0%	−4.9%	+0.4%
Gross profit	$1.10B	$1.75B	$1.97B	$1.06B	$1.07B	$1.38B	$1.62B	$1.30B	$1.14B	$902.0M
Gross margin	20.4%	28.2%	29.7%	19.2%	21.5%	21.8%	23.7%	21.4%	19.8%	15.5%
Net income	$7.00M	$746.0M	$995.0M	−$52.0M	$219.0M	$608.0M	$578.0M	−$253.0M	$69.0M	−$386.0M
Net margin	0.1%	12.1%	15.0%	−0.9%	4.4%	9.6%	8.5%	−4.2%	1.2%	−6.6%
EPS (diluted)	$0.04	$3.91	$5.45	−$0.32	$1.32	$3.60	$3.65	−$1.70	$0.46	−$2.57
Balance sheet
Cash and equivalents	$902.0M	$1.56B	$1.20B	$943.0M	$1.10B	$1.45B	$1.10B	$1.20B	$713.0M	$670.0M
Total assets	$6.06B	$7.29B	$7.36B	$7.26B	$7.08B	$7.55B	$7.64B	$8.24B	$7.51B	$7.38B
Total liabilities	$5.96B	$6.43B	$6.34B	$6.56B	$6.27B	$6.47B	$6.53B	$7.52B	$6.94B	$7.13B
Long-term debt	$3.53B	$4.10B	$3.96B	$4.03B	$4.00B	$3.72B	$3.59B	$3.99B	$4.06B	$4.10B
Shareholders' equity	$100.0M	$860.0M	$1.01B	$689.0M	$813.0M	$1.08B	$1.11B	$721.0M	$571.0M	$250.0M
Cash flow
Operating cash flow	$594.0M	$640.0M	$1.14B	$650.0M	$807.0M	$814.0M	$755.0M	$556.0M	−$633.0M	$264.0M
Capital expenditure	$338.0M	$411.0M	$498.0M	$481.0M	$267.0M	$277.0M	$307.0M	$370.0M	$360.0M	$213.0M
Free cash flow	$256.0M	$229.0M	$642.0M	$169.0M	$540.0M	$537.0M	$448.0M	$186.0M	−$993.0M	$51.0M
Dividends paid	$22.0M	$22.0M	$148.0M	$164.0M	$164.0M	$164.0M	$154.0M	$149.0M	$148.0M	$78.0M
Share buybacks	$0	$106.0M	$644.0M	$322.0M	$0	$173.0M	$495.0M	$69.0M	—	—

RevenueNet incomeNet margin (right axis, %)

Chemours quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$1.51B	$1.36B	$1.37B	$1.61B	$1.50B	$1.33B	$1.38B	$1.59B
Growth (year over year)	+0.5%	−0.7%	+0.4%	+3.9%	−0.9%	−2.1%	+1.0%	−1.5%
Gross profit	$286.0M	$264.0M	$236.0M	$278.0M	$233.0M	$155.0M	$212.0M	$286.0M
Gross margin	19.0%	19.4%	17.3%	17.2%	15.6%	11.7%	15.4%	18.0%
Net income	−$32.0M	−$13.0M	−$5.00M	−$380.0M	$46.0M	−$47.0M	−$29.0M	−$274.0M
Net margin	−2.1%	−1.0%	−0.4%	−23.5%	3.1%	−3.5%	−2.1%	−17.2%
EPS (diluted)	−$0.22	−$0.07	−$0.03	−$2.53	$0.31	−$0.32	−$0.19	−$1.81
Balance sheet
Cash and equivalents	$596.0M	$713.0M	$464.0M	$502.0M	$613.0M	$670.0M	$563.0M	$671.0M
Total assets	$7.46B	$7.51B	$7.38B	$7.46B	$7.55B	$7.38B	$7.27B	$7.15B
Total liabilities	$6.81B	$6.94B	$6.81B	$7.23B	$7.27B	$7.13B	$7.05B	$7.20B
Long-term debt	$3.99B	$4.06B	$4.07B	$4.11B	$4.10B	$4.10B	$4.10B	$3.84B
Shareholders' equity	$643.0M	$571.0M	$566.0M	$228.0M	$274.0M	$250.0M	$215.0M	−$49.0M
Cash flow
Operating cash flow	$139.0M	$138.0M	−$112.0M	$93.0M	$146.0M	$137.0M	−$44.0M	$158.0M
Capital expenditure	$76.0M	$109.0M	$84.0M	$43.0M	$41.0M	$45.0M	$49.0M	$44.0M
Free cash flow	$63.0M	$29.0M	−$196.0M	$50.0M	$105.0M	$92.0M	−$93.0M	$114.0M
Dividends paid	$38.0M	$36.0M	$37.0M	$13.0M	$13.0M	$15.0M	$13.0M	$13.0M

From Chemours's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Chemours

The Chemours Company, headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015. The company's primary products are refrigerants, titanium dioxide pigment, and industrial fluoropolymer resins. The company operates 28 major production facilities in 8 countries and serves approximately 2,400 customers in approximately 110 countries.

Source: Wikipedia — Chemours